Transcription factor EB: an emerging drug target for neurodegenerative disorders

JX Song, J Liu, Y Jiang, ZY Wang, M Li - Drug Discovery Today, 2021 - Elsevier
Highlights•Transcription factor EB orchestrates the autophagy–lysosomal pathway.•Deficient
activation of transcription factor EB is closely associated with the pathogenesis of …
被引用次数：34 相关文章

Transcription factor EB: an emerging drug target for neurodegenerative disorders.

JX Song, J Liu, Y Jiang, ZY Wang, M Li - Drug Discovery Today, 2020 - europepmc.org
The discovery of transcription factor EB (TFEB) as a master regulator of the autophagy-
lysosomal pathway (ALP) has triggered increasing numbers of studies that aim to explore …

Transcription factor EB: an emerging drug target for neurodegenerative disorders

JX Song, J Liu, Y Jiang, ZY Wang… - Drug discovery …, 2021 - pubmed.ncbi.nlm.nih.gov
The discovery of transcription factor EB (TFEB) as a master regulator of the autophagy-
lysosomal pathway (ALP) has triggered increasing numbers of studies that aim to explore …